Regions Financial Corp Agios Pharmaceuticals, Inc. Transaction History

Regions Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$46.17 - $68.1 $507 - $749	-11 Closed	0 $0
Q3 2018 Oct 22, 2018	SELL	$71.67 - $91.95 $358 - $459	-5 Reduced 31.25%	11 $1,000
Q2 2018 Jul 26, 2018	BUY	$73.22 - $99.55 $1,171 - $1,592	16 New	16 $1,000
Q1 2018 Apr 18, 2018	SELL	$59.83 - $86.53 $5,983 - $8,653	-100 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$52.12 - $72.33 $5,212 - $7,233	100	100 $6,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.8B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.